{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388844699595776.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.2337/dc10-2149"}},{"identifier":{"@type":"URI","@value":"https://diabetesjournals.org/care/article-pdf/34/5/1089/607767/1089.pdf"}},{"identifier":{"@type":"PMID","@value":"21430086"}}],"dc:title":[{"@value":"Basal Insulin Requirement Is ∼30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:sec><jats:title>OBJECTIVE</jats:title><jats:p>To investigate the basal insulin requirement in total daily insulin dose in Japanese type 1 diabetic patients who use the insulin pump.</jats:p></jats:sec><jats:sec><jats:title>RESEARCH DESIGN AND METHODS</jats:title><jats:p>The basal insulin requirement in 35 type 1 diabetic patients without detectable C-peptide using the insulin pump (Paradigm 712) was investigated during 2–3 weeks of hospitalization. The patients were served diabetic diets of 25–30 kcal/kg ideal body weight. Each meal omission was done to confirm stable blood glucose levels within 30 mg/dL variance until the next meal. Target blood glucose level was set at 100 mg/dL before each meal and 150 mg/dL at 2 h after each meal.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>Total daily insulin dose was 31.6 ± 8.5 units, and total basal insulin requirement was 8.7 ± 2.9 units, which was 27.7 ± 6.9% of the total daily dose.</jats:p></jats:sec><jats:sec><jats:title>CONCLUSIONS</jats:title><jats:p>Basal insulin requirement is ∼30% of the total daily dose in Japanese type 1 diabetic patients who use the insulin pump.</jats:p></jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383388844699595776","@type":"Researcher","foaf:name":[{"@value":"Akio Kuroda"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595785","@type":"Researcher","foaf:name":[{"@value":"Hideaki Kaneto"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595784","@type":"Researcher","foaf:name":[{"@value":"Tetsuyuki Yasuda"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595782","@type":"Researcher","foaf:name":[{"@value":"Munehide Matsuhisa"}],"jpcoar:affiliationName":[{"@value":"Diabetes Clinical Research and Development Center, Tokushima University, Tokushima, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595777","@type":"Researcher","foaf:name":[{"@value":"Kazuyuki Miyashita"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595778","@type":"Researcher","foaf:name":[{"@value":"Noritaka Fujiki"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595779","@type":"Researcher","foaf:name":[{"@value":"Keiko Fujisawa"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595787","@type":"Researcher","foaf:name":[{"@value":"Tsunehiko Yamamoto"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595783","@type":"Researcher","foaf:name":[{"@value":"Mitsuyoshi Takahara"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595781","@type":"Researcher","foaf:name":[{"@value":"Fumie Sakamoto"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595780","@type":"Researcher","foaf:name":[{"@value":"Taka-aki Matsuoka"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844699595786","@type":"Researcher","foaf:name":[{"@value":"Iichiro Shimomura"}],"jpcoar:affiliationName":[{"@value":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01495992"},{"@type":"EISSN","@value":"19355548"}],"prism:publicationName":[{"@value":"Diabetes Care"}],"dc:publisher":[{"@value":"American Diabetes Association"}],"prism:publicationDate":"2011-04-20","prism:volume":"34","prism:number":"5","prism:startingPage":"1089","prism:endingPage":"1090"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["http://creativecommons.org/licenses/by-nc-nd/3.0/"],"url":[{"@id":"https://diabetesjournals.org/care/article-pdf/34/5/1089/607767/1089.pdf"}],"createdAt":"2011-03-24","modifiedAt":"2023-06-05","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Blood%20Glucose","dc:title":"Blood Glucose"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=C-Peptide","dc:title":"C-Peptide"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Insulin,%20Long-Acting","dc:title":"Insulin, Long-Acting"},{"@id":"https://cir.nii.ac.jp/all?q=Young%20Adult","dc:title":"Young Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Diabetes%20Mellitus,%20Type%201","dc:title":"Diabetes Mellitus, Type 1"},{"@id":"https://cir.nii.ac.jp/all?q=Insulin%20Infusion%20Systems","dc:title":"Insulin Infusion Systems"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Hypoglycemic%20Agents","dc:title":"Hypoglycemic Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Insulin","dc:title":"Insulin"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Original%20Research","dc:title":"Original Research"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360567185766427136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Improvement in glycemic control through changes in insulin regimens: findings from a Japanese cohort of children and adolescents with type 1 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640193666688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of insulin degludec and insulin glargine on day-to-day fasting plasma glucose variability in individuals with type 1 diabetes: a multicentre, randomised, crossover study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593694751744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412891775559808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205746605184","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY"},{"@language":"ja","@value":"CSII (Continuous Subcutaneous Insulin Infusion) 療法とは"},{"@language":"ja-Kana","@value":"CSII(Continuous Subcutaneous Insulin Infusion)リョウホウ トワ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206297253632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390293268648707840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study"}]},{"@id":"https://cir.nii.ac.jp/crid/1521980706152634368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan : Study of Adults' Glycemia in T1DM subanalysis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.2337/dc10-2149"},{"@type":"OPENAIRE","@value":"doi_dedup___::0573cb22b30cd80fa15b189b2d03abd7"},{"@type":"CROSSREF","@value":"10.14789/pjmj.58.485_references_DOI_Nd1m6vsHjP4VxJ69gP3TYom6n6c"},{"@type":"CROSSREF","@value":"10.1016/j.heliyon.2019.e01257_references_DOI_Nd1m6vsHjP4VxJ69gP3TYom6n6c"},{"@type":"CROSSREF","@value":"10.3164/jcbn.22-7_references_DOI_Nd1m6vsHjP4VxJ69gP3TYom6n6c"},{"@type":"CROSSREF","@value":"10.1111/pedi.12409_references_DOI_Nd1m6vsHjP4VxJ69gP3TYom6n6c"},{"@type":"CROSSREF","@value":"10.1007/s13340-021-00504-7_references_DOI_Nd1m6vsHjP4VxJ69gP3TYom6n6c"},{"@type":"CROSSREF","@value":"10.1007/s00125-015-3648-y_references_DOI_Nd1m6vsHjP4VxJ69gP3TYom6n6c"},{"@type":"CROSSREF","@value":"10.1111/jdi.13547_references_DOI_Nd1m6vsHjP4VxJ69gP3TYom6n6c"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej14-0487_references_DOI_Nd1m6vsHjP4VxJ69gP3TYom6n6c"}]}